WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?

BenzingaFeb 16 09:45 ET

Revenues Working Against Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Share Price Following 26% Dive

Simply Wall StFeb 15 07:29 ET

Druckenmiller's Duquesne Adds Airlines, Exits Microsoft, Broadcom, Others

Seeking AlphaFeb 14 17:49 ET

Teva Pharmaceutical Industries Insider Sold Shares Worth $2,886,565, According to a Recent SEC Filing

MT NewswiresFeb 14 16:08 ET

Spotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activity

BenzingaFeb 10 14:15 ET

Axsome Therapeutics Shares Jump Almost 20%, Resolves Generic Patent Litigation With Teva Over Depression Drug

BenzingaFeb 10 13:58 ET